Is new Alzheimer’s drug a ‘game-changer?
by Liz DeSantis
An experimental drug shattered and removed toxic plaques in the brains of patients with early-stage Alzheimer’s disease, researchers said Thursday.
Given to patients once a month for a year, infusions of the drug aducanumab cleared the brain of the deposits, which experts believe play a crucial role in disrupting cellular processes and blocking communication among nerve cells.